Key Takeaways Berkshire Hathaway has recorded a $3.8 billion impairment charge on its Kraft Heinz investment, reflecting the food giant’s persistent underperformance and struggles with shifting consumer preferences. The writedown...
Key Takeaways AMD’s upcoming Q2 2025 earnings are a critical test of its AI strategy, with investors focused on whether the company can successfully monetise its investments in Instinct GPUs...
Key Takeaways Manufacturing defects in Pratt & Whitney engines have grounded a substantial portion of Wizz Air’s fleet, with around 15% of its aircraft out of service as of mid-2025....
Key Takeaways An equity with a depressed market capitalisation could be poised for a 3x to 5x uplift, with a potential valuation range between €4.5 billion and €7.2 billion. This...
Key Takeaways Wizz Air’s highly leveraged balance sheet presents a high-risk, high-reward scenario, where debt reduction could disproportionately increase equity value. Operational improvements are underway, with Q1 FY2026 results showing...
Key Takeaways Ancillary revenues are a critical strategic pillar for European low-cost carriers, offering a crucial buffer against fare volatility and operational disruptions. A higher share of ancillary revenues (above...
Robinhood plans to launch banking services by the end of the current quarter, a strategic move to diversify its revenue beyond the unpredictability of transaction-based income. The new banking arm...
Explore why TransMedics is capturing investor attention with a compelling 35% upside potential. Rated a "Buy" with a price target of $195, the company revolutionises organ transplantation through its innovative...
Key Takeaways High free cash flow (FCF) yields, particularly those exceeding 10%, are a potent indicator of financial resilience and the potential for substantial long-term returns. Investor psychology frequently leads...
Key Takeaways The FDA has expanded its approval for Novo Nordisk’s Alhemo, enabling its use as a once-daily prophylactic treatment for haemophilia A and B in patients aged 12 and...
